Research and Markets: GSK’s Flovent (Asthma) – Forecast and Market Analysis … – Business Wire (press release)

Research and Markets: GSK's Flovent (Asthma) – Forecast and Market Analysis …
Business Wire (press release)
Originally approved by the Food and Drug Administration (FDA) in 1996, GSK's Flovent (fluticasone propionate) is a synthetic ICS therapy with potent anti-inflammatory activity. It is used for the maintenance treatment of asthma prophylactically in …
Research and Markets: GSK's Bosatria (Mepolizumab) Asthma Treatment …Rock Hill Herald (press release)

all 4 news articles »